Ulm, Germany

Dunja Kotschenreuther

This inventor holds 1 USPTO granted patent. Top assignee: Merckle Gmbh. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dunja Kotschenreuther. Retrieved from https://idiyas.com/inventor/dunja-kotschenreuther

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dunja Kotschenreuther: Innovator in Pharmaceutical Chemistry

Introduction

Dunja Kotschenreuther is a prominent inventor based in Ulm, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development of new compounds.

Latest Patents

Kotschenreuther holds a patent for 2-thio-substituted imidazole derivatives, which are valuable in the pharmaceutical industry. The invention relates to compounds that exhibit immunomodulating and cytokine-release-inhibiting actions. These compounds are particularly suitable for treating disorders associated with a disturbed immune system. Her patent is a testament to her expertise and dedication to advancing medical science.

Career Highlights

Dunja Kotschenreuther is associated with Merckle GmbH, a well-respected company in the pharmaceutical sector. Her work at Merckle has allowed her to focus on developing innovative solutions that address critical health issues. With her extensive knowledge and experience, she has become a key figure in her field.

Collaborations

Kotschenreuther collaborates with notable colleagues, including Stefan Laufer and Philipp Merckle. These partnerships enhance her research efforts and contribute to the success of her projects.

Conclusion

Dunja Kotschenreuther is a remarkable inventor whose work in pharmaceutical chemistry is making a significant impact. Her innovative patents and collaborations reflect her commitment to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…